Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
复制标题
肺腺癌中裂解和聚腺苷酸化特异性因子 4 的上调及其对癌细胞存活和增殖的关键作用
DOI:
10.1371/journal.pone.0082728
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Deng W
中科院分区:
文献类型:
--
作者:
Chen W;Guo W;Li M;Shi D;Tian Y;Li Z;Wang J;Fu L;Xiao X;Liu QQ;Wang S;Huang W;Deng W
Cleavage and polyadenylation specific factor 4 (CPSF4), a member of CPSF complex, plays a key role in mRNA polyadenylation and mRNA 3′ ends maturation. However, its possible role in lung cancer pathogenesis is unknown. In this study, we investigated the biological role and clinical significance of CPSF4 in lung cancer growth and survival and elucidated its underlying molecular mechanisms. We found that CPSF4 was highly expressed in lung adenocarcinoma cell lines and tumor tissue but was undetectable in 8 normal human tissues. We also found that CPSF4 overexpression was correlated with poor overall survival in patients with lung adenocarcinomas (P<0.001). Multivariate survival analyses revealed that higher CPSF4 expression was an independent prognostic factor for overall survival of the patients with lung adenocarcinomas. Suppression of CPSF4 by siRNA inhibited lung cancer cells proliferation, colony formation, and induced apoptosis. Mechanism studies revealed that these effects were achieved through simultaneous modulation of multiple signaling pathways. Knockdown of CPSF4 expression by siRNA markedly inhibited the phosphorylation of PI3K, AKT and ERK1/2 and JNK proteins. In contrast, the ectopic expression of CPSF4 had the opposite effects. Moreover, CPSF4 knockdown also induced the cleavage of caspase-3 and caspse-9 proteins. Collectively, these results demonstrate that CPSF4 plays a critical role in regulating lung cancer cell proliferation and survival and may be a potential prognostic biomarker and therapeutic target for lung adenocarcinoma.
登录
查看更多内容
影响因子:
16
作者:
Nemeroff, ME;Barabino, SML;Krug, RM
通讯作者:
Krug, RM
影响因子:
11.4
作者:
de Vries, H;Rüegsegger, U;Keller, W
通讯作者:
Keller, W
影响因子:
10.5
作者:
Barabino, SML;Hubner, W;Keller, W
通讯作者:
Keller, W
影响因子:
11.2
作者:
Ueda, Kentaro;Kawashima, Hiroyuki;Ji, Lin
通讯作者:
Ji, Lin
DOI:
10.1093/jnci/djn389
发表时间:
2008-12-03
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
Jemal A;Thun MJ;Ries LA;Howe HL;Weir HK;Center MM;Ward E;Wu XC;Eheman C;Anderson R;Ajani UA;Kohler B;Edwards BK
通讯作者:
Edwards BK